

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.80181324 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 5.62850018 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 5.20649974 |
| 4 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.91623363 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.87097771 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.87097771 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.87097771 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.87097771 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.87097771 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.87097771 |
| 11 | * regulation of sequestering of triglyceride (GO:0010889) | 4.76922667 |
| 12 | cellular extravasation (GO:0045123) | 4.66334456 |
| 13 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.52739393 |
| 14 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.48870735 |
| 15 | detection of other organism (GO:0098543) | 4.48739421 |
| 16 | response to peptidoglycan (GO:0032494) | 4.34256047 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.32600760 |
| 18 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.25004297 |
| 19 | neutrophil activation (GO:0042119) | 4.20806224 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.18524668 |
| 21 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.14582406 |
| 22 | thioester biosynthetic process (GO:0035384) | 4.12767833 |
| 23 | acyl-CoA biosynthetic process (GO:0071616) | 4.12767833 |
| 24 | neutrophil mediated immunity (GO:0002446) | 4.10910184 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.00611530 |
| 26 | granulocyte activation (GO:0036230) | 3.96526259 |
| 27 | fatty acid elongation (GO:0030497) | 3.95834777 |
| 28 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.87530174 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85211421 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.83344757 |
| 31 | detection of bacterium (GO:0016045) | 3.82350326 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.77988745 |
| 33 | iron ion import (GO:0097286) | 3.74132469 |
| 34 | triglyceride biosynthetic process (GO:0019432) | 3.74109070 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.71064353 |
| 36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.69190034 |
| 37 | fatty acid transmembrane transport (GO:1902001) | 3.68101724 |
| 38 | positive regulation of mast cell activation (GO:0033005) | 3.66614717 |
| 39 | macrophage activation (GO:0042116) | 3.65048008 |
| 40 | acylglycerol biosynthetic process (GO:0046463) | 3.64929570 |
| 41 | neutral lipid biosynthetic process (GO:0046460) | 3.64929570 |
| 42 | microglial cell activation (GO:0001774) | 3.58893780 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 3.58855549 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.58236973 |
| 45 | biotin metabolic process (GO:0006768) | 3.56507485 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56449306 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.56449306 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.56424395 |
| 49 | keratinization (GO:0031424) | 3.48130655 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.41528666 |
| 51 | linoleic acid metabolic process (GO:0043651) | 3.41277244 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.40383108 |
| 53 | brown fat cell differentiation (GO:0050873) | 3.37723111 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.36396117 |
| 55 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.35145476 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 3.34106648 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 3.32568434 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.32568434 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.30732325 |
| 60 | respiratory burst (GO:0045730) | 3.30628576 |
| 61 | carnitine shuttle (GO:0006853) | 3.30406609 |
| 62 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.29643718 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 3.29033364 |
| 64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.28987545 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27935153 |
| 66 | response to host immune response (GO:0052572) | 3.27935153 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24433600 |
| 68 | carnitine transmembrane transport (GO:1902603) | 3.24277676 |
| 69 | regulation of cholesterol storage (GO:0010885) | 3.24145217 |
| 70 | oxygen transport (GO:0015671) | 3.24141544 |
| 71 | leukocyte degranulation (GO:0043299) | 3.23460235 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.20080679 |
| 73 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.18683939 |
| 74 | carnitine transport (GO:0015879) | 3.17006421 |
| 75 | amino-acid betaine transport (GO:0015838) | 3.17006421 |
| 76 | myeloid leukocyte mediated immunity (GO:0002444) | 3.07503218 |
| 77 | lipoxygenase pathway (GO:0019372) | 3.06324721 |
| 78 | response to host (GO:0075136) | 3.04545945 |
| 79 | response to host defenses (GO:0052200) | 3.04545945 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.04545945 |
| 81 | thioester metabolic process (GO:0035383) | 3.03792465 |
| 82 | acyl-CoA metabolic process (GO:0006637) | 3.03792465 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02971059 |
| 84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02612996 |
| 85 | positive regulation of leukocyte degranulation (GO:0043302) | 3.02480568 |
| 86 | fatty acid oxidation (GO:0019395) | 3.02277480 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.00754724 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 3.00466911 |
| 89 | regulation of lipoprotein metabolic process (GO:0050746) | 2.97998708 |
| 90 | lipid oxidation (GO:0034440) | 2.97079317 |
| 91 | fatty acid catabolic process (GO:0009062) | 2.95749450 |
| 92 | positive regulation of lipid storage (GO:0010884) | 2.94767354 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94452146 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93620233 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93017543 |
| 96 | dendritic cell migration (GO:0036336) | 2.91902872 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89521197 |
| 98 | L-phenylalanine catabolic process (GO:0006559) | 2.89142747 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.89142747 |
| 100 | phagocytosis, recognition (GO:0006910) | 2.88033022 |
| 101 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87422464 |
| 102 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86961051 |
| 103 | embryonic process involved in female pregnancy (GO:0060136) | 2.86813631 |
| 104 | valine metabolic process (GO:0006573) | 2.86685485 |
| 105 | lipid storage (GO:0019915) | 2.85554892 |
| 106 | * triglyceride metabolic process (GO:0006641) | 2.85188029 |
| 107 | gas transport (GO:0015669) | 2.84198301 |
| 108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.83542614 |
| 109 | * triglyceride catabolic process (GO:0019433) | 2.82910406 |
| 110 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.80997366 |
| 111 | cellular response to arsenic-containing substance (GO:0071243) | 2.77138051 |
| 112 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.76923492 |
| 113 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.76849076 |
| 114 | very long-chain fatty acid metabolic process (GO:0000038) | 2.74930334 |
| 115 | positive regulation of fatty acid oxidation (GO:0046321) | 2.74596080 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 2.74589144 |
| 117 | multicellular organism reproduction (GO:0032504) | 2.74331529 |
| 118 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.73696027 |
| 119 | lipid particle organization (GO:0034389) | 2.71710377 |
| 120 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.71230895 |
| 121 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.71080174 |
| 122 | negative regulation of interleukin-17 production (GO:0032700) | 2.70669016 |
| 123 | cytokine secretion (GO:0050663) | 2.70584765 |
| 124 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70551676 |
| 125 | cholesterol biosynthetic process (GO:0006695) | 2.68924426 |
| 126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68617236 |
| 127 | axon ensheathment in central nervous system (GO:0032291) | 2.68532843 |
| 128 | central nervous system myelination (GO:0022010) | 2.68532843 |
| 129 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68300011 |
| 130 | surfactant homeostasis (GO:0043129) | 2.68240621 |
| 131 | positive regulation of regulated secretory pathway (GO:1903307) | 2.64630347 |
| 132 | leukocyte aggregation (GO:0070486) | 2.64047820 |
| 133 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.63824140 |
| 134 | response to phenylpropanoid (GO:0080184) | 2.63669486 |
| 135 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.63226298 |
| 136 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.62776579 |
| 137 | * acylglycerol metabolic process (GO:0006639) | 2.62758746 |
| 138 | myelin maintenance (GO:0043217) | 2.62712680 |
| 139 | hypotonic response (GO:0006971) | 2.62370732 |
| 140 | acylglycerol homeostasis (GO:0055090) | 2.62145544 |
| 141 | triglyceride homeostasis (GO:0070328) | 2.62145544 |
| 142 | negative regulation of interleukin-6 production (GO:0032715) | 2.61330046 |
| 143 | complement activation, alternative pathway (GO:0006957) | 2.61287735 |
| 144 | hepatocyte apoptotic process (GO:0097284) | 2.60396813 |
| 145 | L-phenylalanine metabolic process (GO:0006558) | 2.60292500 |
| 146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.60292500 |
| 147 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.60164831 |
| 148 | response to lipoprotein particle (GO:0055094) | 2.59791389 |
| 149 | regulation of platelet aggregation (GO:0090330) | 2.59350264 |
| 150 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.57417681 |
| 151 | * neutral lipid metabolic process (GO:0006638) | 2.56598254 |
| 152 | ethanol metabolic process (GO:0006067) | 2.56573543 |
| 153 | carnitine metabolic process (GO:0009437) | 2.56274371 |
| 154 | superoxide anion generation (GO:0042554) | 2.56177045 |
| 155 | regulation of macrophage cytokine production (GO:0010935) | 2.56163833 |
| 156 | * positive regulation of lipid catabolic process (GO:0050996) | 2.55193536 |
| 157 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.55109150 |
| 158 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.55109150 |
| 159 | quaternary ammonium group transport (GO:0015697) | 2.54514694 |
| 160 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54250267 |
| 161 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.54145728 |
| 162 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.54113603 |
| 163 | long-chain fatty acid transport (GO:0015909) | 2.53797760 |
| 164 | positive regulation of interleukin-6 production (GO:0032755) | 2.53658591 |
| 165 | branched-chain amino acid metabolic process (GO:0009081) | 2.53372984 |
| 166 | intracellular lipid transport (GO:0032365) | 2.52817385 |
| 167 | creatine metabolic process (GO:0006600) | 2.52476268 |
| 168 | germinal center formation (GO:0002467) | 2.52395418 |
| 169 | * regulation of triglyceride catabolic process (GO:0010896) | 2.52266776 |
| 170 | glycerol metabolic process (GO:0006071) | 2.52248659 |
| 171 | myeloid leukocyte activation (GO:0002274) | 2.50965040 |
| 172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49870448 |
| 173 | negative regulation of T cell mediated immunity (GO:0002710) | 2.49622149 |
| 174 | negative regulation of lipase activity (GO:0060192) | 2.49530757 |
| 175 | erythrocyte development (GO:0048821) | 2.48554745 |
| 176 | heme transport (GO:0015886) | 2.48124223 |
| 177 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.48117762 |
| 178 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.48117762 |
| 179 | positive regulation of macrophage cytokine production (GO:0060907) | 2.47540463 |
| 180 | cell wall macromolecule metabolic process (GO:0044036) | 2.46342508 |
| 181 | cell wall macromolecule catabolic process (GO:0016998) | 2.46342508 |
| 182 | negative regulation of protein autophosphorylation (GO:0031953) | 2.46040970 |
| 183 | regulation of regulated secretory pathway (GO:1903305) | 2.45076055 |
| 184 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.44998622 |
| 185 | monocarboxylic acid catabolic process (GO:0072329) | 2.43277424 |
| 186 | membrane raft organization (GO:0031579) | 2.43100571 |
| 187 | * neutral lipid catabolic process (GO:0046461) | 2.43040507 |
| 188 | * acylglycerol catabolic process (GO:0046464) | 2.43040507 |
| 189 | NADP metabolic process (GO:0006739) | 2.42724741 |
| 190 | short-chain fatty acid metabolic process (GO:0046459) | 2.42505686 |
| 191 | import into cell (GO:0098657) | 2.41920808 |
| 192 | sulfur amino acid catabolic process (GO:0000098) | 2.41622940 |
| 193 | positive regulation of p38MAPK cascade (GO:1900745) | 2.41121410 |
| 194 | desmosome organization (GO:0002934) | 2.40594521 |
| 195 | growth hormone receptor signaling pathway (GO:0060396) | 2.39958486 |
| 196 | reproduction (GO:0000003) | 2.39289584 |
| 197 | adhesion of symbiont to host (GO:0044406) | 2.38882859 |
| 198 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.38618858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.75595040 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.61657939 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.18935998 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74216558 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25591944 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.06322670 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.04510901 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.92783314 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91635386 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81653172 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79873996 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.76856457 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.74086575 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.59167752 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.56175430 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44409704 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.44328061 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.42322514 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.41293377 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38856545 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34583193 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30275411 |
| 23 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.25947644 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23210797 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15950332 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14765179 |
| 27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05674003 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00853859 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99079349 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97247004 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83249544 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73829671 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73727440 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71976532 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70886865 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.68320657 |
| 37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.63780187 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63366874 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60798879 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.60757676 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.59928329 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58581699 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57148106 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.56040969 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.55243017 |
| 46 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54748478 |
| 47 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54748478 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.53798697 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52630339 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51558992 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51441444 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50986428 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48842154 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48082686 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45741390 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44417712 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43138605 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42244317 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41547365 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41506034 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40100019 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40047647 |
| 63 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39186370 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37772683 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.37313098 |
| 66 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.37076338 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36504562 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35644579 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34683421 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33631078 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32497661 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30339007 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30144668 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28553786 |
| 75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27300047 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26095287 |
| 77 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.25318603 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24896266 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24572944 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.23250696 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22113124 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21992715 |
| 83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21247064 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21240969 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20169308 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19807362 |
| 87 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19758917 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18466249 |
| 89 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18094141 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.16350553 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15927709 |
| 92 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14956458 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13213981 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.13138960 |
| 95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12507157 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12507157 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12497939 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11638455 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11617567 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 1.10655741 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10014410 |
| 102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09692090 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09680322 |
| 104 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.06819907 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06490754 |
| 106 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06237838 |
| 107 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05544600 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05400639 |
| 109 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04589631 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03109938 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03109938 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03077691 |
| 113 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02943061 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00364587 |
| 115 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00158157 |
| 116 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.00144605 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00102909 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00074522 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99948491 |
| 120 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99877328 |
| 121 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.99840497 |
| 122 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99291430 |
| 123 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96596438 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95601805 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95459549 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95394365 |
| 127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94070665 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93804686 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93303603 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93245620 |
| 131 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91467374 |
| 132 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.90983956 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87685577 |
| 134 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87386956 |
| 135 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82974240 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82734877 |
| 137 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82605987 |
| 138 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82337046 |
| 139 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82299458 |
| 140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.82088293 |
| 141 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81769260 |
| 142 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80041974 |
| 143 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79489690 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79244476 |
| 145 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78626677 |
| 146 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.77219897 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76560148 |
| 148 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76550168 |
| 149 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76130395 |
| 150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76076727 |
| 151 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.75961703 |
| 152 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.74096973 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74023265 |
| 154 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73725413 |
| 155 | CBP_21632823_ChIP-Seq_H3396_Human | 0.73367930 |
| 156 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73225089 |
| 157 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71994994 |
| 158 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71905302 |
| 159 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.71731208 |
| 160 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71502678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 3.77308301 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.45378091 |
| 3 | MP0003303_peritoneal_inflammation | 2.87544129 |
| 4 | MP0005275_abnormal_skin_tensile | 2.83587066 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.57275791 |
| 6 | MP0002796_impaired_skin_barrier | 2.54724247 |
| 7 | MP0005666_abnormal_adipose_tissue | 2.53380390 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.49573742 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.49074982 |
| 10 | MP0004130_abnormal_muscle_cell | 2.46630200 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 2.46605410 |
| 12 | MP0005360_urolithiasis | 2.46170797 |
| 13 | MP0005410_abnormal_fertilization | 2.44408212 |
| 14 | MP0001881_abnormal_mammary_gland | 2.32257325 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.25875793 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.16138573 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.02627187 |
| 18 | MP0004272_abnormal_basement_membrane | 1.89135997 |
| 19 | MP0003724_increased_susceptibility_to | 1.88645834 |
| 20 | MP0003195_calcinosis | 1.86802846 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.86035426 |
| 22 | MP0005375_adipose_tissue_phenotype | 1.84914335 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.83003862 |
| 24 | MP0004782_abnormal_surfactant_physiolog | 1.81946872 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.79415252 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.77424512 |
| 27 | MP0005025_abnormal_response_to | 1.75815681 |
| 28 | MP0002060_abnormal_skin_morphology | 1.75545846 |
| 29 | MP0005365_abnormal_bile_salt | 1.74254041 |
| 30 | MP0002971_abnormal_brown_adipose | 1.74216726 |
| 31 | MP0003186_abnormal_redox_activity | 1.74156385 |
| 32 | MP0008004_abnormal_stomach_pH | 1.74004391 |
| 33 | MP0005451_abnormal_body_composition | 1.72964128 |
| 34 | MP0005083_abnormal_biliary_tract | 1.70327845 |
| 35 | MP0000579_abnormal_nail_morphology | 1.68023028 |
| 36 | MP0006082_CNS_inflammation | 1.67586277 |
| 37 | MP0004381_abnormal_hair_follicle | 1.67337383 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.66232217 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.64674117 |
| 40 | MP0000920_abnormal_myelination | 1.64414853 |
| 41 | MP0003011_delayed_dark_adaptation | 1.64295415 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.63661430 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.59127198 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.58434693 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.58018796 |
| 46 | MP0003690_abnormal_glial_cell | 1.57844403 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.56263125 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.56263125 |
| 49 | MP0001800_abnormal_humoral_immune | 1.55404095 |
| 50 | MP0006054_spinal_hemorrhage | 1.55265360 |
| 51 | MP0002132_abnormal_respiratory_system | 1.54944213 |
| 52 | MP0009840_abnormal_foam_cell | 1.54394898 |
| 53 | MP0001958_emphysema | 1.51211458 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.49497170 |
| 55 | MP0002723_abnormal_immune_serum | 1.48980631 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.47671605 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.45163292 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.44182537 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.42439227 |
| 60 | MP0005501_abnormal_skin_physiology | 1.42361671 |
| 61 | MP0001819_abnormal_immune_cell | 1.41710353 |
| 62 | MP0004883_abnormal_blood_vessel | 1.41570378 |
| 63 | MP0000858_altered_metastatic_potential | 1.41217105 |
| 64 | MP0000343_altered_response_to | 1.40436571 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.39777223 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.39429414 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.38809018 |
| 68 | MP0003436_decreased_susceptibility_to | 1.34886120 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.34505451 |
| 70 | MP0010678_abnormal_skin_adnexa | 1.33587782 |
| 71 | MP0000383_abnormal_hair_follicle | 1.33351843 |
| 72 | MP0000647_abnormal_sebaceous_gland | 1.32964818 |
| 73 | MP0000685_abnormal_immune_system | 1.31388407 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.30716356 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30130950 |
| 76 | MP0005334_abnormal_fat_pad | 1.29636500 |
| 77 | MP0001661_extended_life_span | 1.24626605 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.24290702 |
| 79 | MP0001216_abnormal_epidermal_layer | 1.21055091 |
| 80 | MP0002405_respiratory_system_inflammati | 1.20978091 |
| 81 | MP0005387_immune_system_phenotype | 1.19810697 |
| 82 | MP0001790_abnormal_immune_system | 1.19810697 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 1.19249428 |
| 84 | MP0002398_abnormal_bone_marrow | 1.18966292 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17199442 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.16367312 |
| 87 | MP0003045_fibrosis | 1.15795531 |
| 88 | MP0000003_abnormal_adipose_tissue | 1.14244081 |
| 89 | MP0000566_synostosis | 1.12323029 |
| 90 | MP0005164_abnormal_response_to | 1.09985051 |
| 91 | MP0001851_eye_inflammation | 1.08787707 |
| 92 | MP0000609_abnormal_liver_physiology | 1.08746005 |
| 93 | MP0002722_abnormal_immune_system | 1.08735980 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 1.08292653 |
| 95 | MP0004147_increased_porphyrin_level | 1.07317259 |
| 96 | MP0002419_abnormal_innate_immunity | 1.06836816 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 1.06596021 |
| 98 | MP0002098_abnormal_vibrissa_morphology | 1.05923656 |
| 99 | MP0005332_abnormal_amino_acid | 1.05288012 |
| 100 | MP0000716_abnormal_immune_system | 1.04570490 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 1.03110258 |
| 102 | MP0008469_abnormal_protein_level | 1.02879823 |
| 103 | MP0000427_abnormal_hair_cycle | 1.01408168 |
| 104 | MP0000689_abnormal_spleen_morphology | 1.00839109 |
| 105 | MP0008260_abnormal_autophagy | 1.00654285 |
| 106 | MP0009764_decreased_sensitivity_to | 0.99952215 |
| 107 | MP0009115_abnormal_fat_cell | 0.99921191 |
| 108 | MP0003828_pulmonary_edema | 0.99176778 |
| 109 | MP0000377_abnormal_hair_follicle | 0.98360935 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.98128090 |
| 111 | MP0004947_skin_inflammation | 0.97431689 |
| 112 | MP0004233_abnormal_muscle_weight | 0.97339001 |
| 113 | MP0005388_respiratory_system_phenotype | 0.97295521 |
| 114 | MP0002133_abnormal_respiratory_system | 0.97295521 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95695215 |
| 116 | MP0010771_integument_phenotype | 0.95212732 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.94873710 |
| 118 | MP0001542_abnormal_bone_strength | 0.94275362 |
| 119 | MP0002429_abnormal_blood_cell | 0.94245236 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.92648272 |
| 121 | MP0005671_abnormal_response_to | 0.92252875 |
| 122 | MP0009785_altered_susceptibility_to | 0.90885997 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.88984824 |
| 124 | MP0003075_altered_response_to | 0.88522939 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.88142338 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.87985673 |
| 127 | MP0002095_abnormal_skin_pigmentation | 0.87622921 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.87496213 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.87141968 |
| 130 | MP0009278_abnormal_bone_marrow | 0.85698053 |
| 131 | MP0003252_abnormal_bile_duct | 0.84606733 |
| 132 | MP0009931_abnormal_skin_appearance | 0.84195890 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.83503798 |
| 134 | MP0005076_abnormal_cell_differentiation | 0.80343820 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.79814212 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.78576668 |
| 137 | MP0005023_abnormal_wound_healing | 0.77212926 |
| 138 | MP0008775_abnormal_heart_ventricle | 0.76732987 |
| 139 | MP0001243_abnormal_dermal_layer | 0.76697668 |
| 140 | MP0001853_heart_inflammation | 0.76613112 |
| 141 | MP0000371_diluted_coat_color | 0.76159268 |
| 142 | MP0002254_reproductive_system_inflammat | 0.75294570 |
| 143 | MP0001666_abnormal_nutrient_absorption | 0.74987718 |
| 144 | MP0001177_atelectasis | 0.73968703 |
| 145 | MP0001191_abnormal_skin_condition | 0.73572446 |
| 146 | MP0005408_hypopigmentation | 0.72410089 |
| 147 | MP0000627_abnormal_mammary_gland | 0.71774440 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.71263553 |
| 149 | MP0003136_yellow_coat_color | 0.70676558 |
| 150 | MP0005390_skeleton_phenotype | 0.70603462 |
| 151 | MP0000604_amyloidosis | 0.70403761 |
| 152 | MP0002168_other_aberrant_phenotype | 0.70322229 |
| 153 | MP0002396_abnormal_hematopoietic_system | 0.69248876 |
| 154 | MP0002970_abnormal_white_adipose | 0.68972805 |
| 155 | MP0005171_absent_coat_pigmentation | 0.68937935 |
| 156 | MP0009763_increased_sensitivity_to | 0.68438450 |
| 157 | MP0003448_altered_tumor_morphology | 0.68047363 |
| 158 | MP0006138_congestive_heart_failure | 0.67988787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 4.29229253 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.16207041 |
| 3 | Myositis (HP:0100614) | 3.96803308 |
| 4 | Orchitis (HP:0100796) | 3.91710057 |
| 5 | Axonal loss (HP:0003447) | 3.74773656 |
| 6 | Spontaneous hematomas (HP:0007420) | 3.69442430 |
| 7 | Optic neuritis (HP:0100653) | 3.67236168 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.67236168 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 3.58158472 |
| 10 | Gingival bleeding (HP:0000225) | 3.57921708 |
| 11 | Parakeratosis (HP:0001036) | 3.56488335 |
| 12 | Poikilocytosis (HP:0004447) | 3.51334341 |
| 13 | Acanthosis nigricans (HP:0000956) | 3.49471447 |
| 14 | Xanthomatosis (HP:0000991) | 3.48056555 |
| 15 | Polycythemia (HP:0001901) | 3.46029552 |
| 16 | Stomatitis (HP:0010280) | 3.45154104 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36801157 |
| 18 | Prolonged bleeding time (HP:0003010) | 3.36037560 |
| 19 | Petechiae (HP:0000967) | 3.30925594 |
| 20 | Microcytic anemia (HP:0001935) | 3.30856601 |
| 21 | Abnormality of nail color (HP:0100643) | 3.26571461 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.24268903 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.19936196 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.13504362 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.06567993 |
| 26 | Acanthocytosis (HP:0001927) | 3.06545400 |
| 27 | Epistaxis (HP:0000421) | 3.06063357 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 3.03587335 |
| 29 | Premature rupture of membranes (HP:0001788) | 2.99491272 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.97585561 |
| 31 | Recurrent skin infections (HP:0001581) | 2.96868746 |
| 32 | Myocardial infarction (HP:0001658) | 2.96542215 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95326344 |
| 34 | Gangrene (HP:0100758) | 2.94052009 |
| 35 | Keratoconjunctivitis (HP:0001096) | 2.90015322 |
| 36 | Epidermoid cyst (HP:0200040) | 2.88485308 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.86429765 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 2.86429765 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.86215924 |
| 40 | Muscle fiber splitting (HP:0003555) | 2.86154724 |
| 41 | Hyperglycinuria (HP:0003108) | 2.84129889 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78670031 |
| 43 | Vascular calcification (HP:0004934) | 2.78387268 |
| 44 | Hydroxyprolinuria (HP:0003080) | 2.77125030 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.77125030 |
| 46 | Abnormal hemoglobin (HP:0011902) | 2.76825024 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.76787384 |
| 48 | Obstructive lung disease (HP:0006536) | 2.76787384 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.71750139 |
| 50 | Abnormal platelet volume (HP:0011876) | 2.71454606 |
| 51 | Pustule (HP:0200039) | 2.69952675 |
| 52 | * Congenital ichthyosiform erythroderma (HP:0007431) | 2.63178854 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.62980725 |
| 54 | Anorexia (HP:0002039) | 2.62505967 |
| 55 | Hypertriglyceridemia (HP:0002155) | 2.62288621 |
| 56 | Complement deficiency (HP:0004431) | 2.58029702 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.55132934 |
| 58 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.54777802 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.54298411 |
| 60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54298411 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.53407322 |
| 62 | Erythema (HP:0010783) | 2.50620394 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.49838644 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.49473901 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.46050720 |
| 66 | Arterial thrombosis (HP:0004420) | 2.45385528 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.44806102 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44591196 |
| 69 | Episodic fever (HP:0001954) | 2.44429232 |
| 70 | Intrahepatic cholestasis (HP:0001406) | 2.44321855 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.43375638 |
| 72 | Thick nail (HP:0001805) | 2.41121526 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.40880428 |
| 74 | Increased mean platelet volume (HP:0011877) | 2.40205525 |
| 75 | Increased serum ferritin (HP:0003281) | 2.37640998 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.36509991 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35997091 |
| 78 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35891924 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 2.34652559 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34652559 |
| 81 | Deep venous thrombosis (HP:0002625) | 2.32824855 |
| 82 | Hypoplasia of the iris (HP:0007676) | 2.32560438 |
| 83 | Hypophosphatemic rickets (HP:0004912) | 2.31803098 |
| 84 | Tetraparesis (HP:0002273) | 2.31789405 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.30530462 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.28707327 |
| 87 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.27984891 |
| 88 | Hypochromic anemia (HP:0001931) | 2.26528023 |
| 89 | Amyloidosis (HP:0011034) | 2.24923677 |
| 90 | Menorrhagia (HP:0000132) | 2.23928554 |
| 91 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23269750 |
| 92 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22475209 |
| 93 | Onycholysis (HP:0001806) | 2.21705614 |
| 94 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.20871578 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.20785229 |
| 96 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20711394 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.19969512 |
| 98 | Stridor (HP:0010307) | 2.18726220 |
| 99 | Nausea (HP:0002018) | 2.15673377 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.14237554 |
| 101 | Encephalitis (HP:0002383) | 2.13920073 |
| 102 | Peripheral demyelination (HP:0011096) | 2.12424903 |
| 103 | Osteomyelitis (HP:0002754) | 2.12072597 |
| 104 | Myoglobinuria (HP:0002913) | 2.11881976 |
| 105 | Abnormality of complement system (HP:0005339) | 2.11062074 |
| 106 | Vasculitis (HP:0002633) | 2.07744154 |
| 107 | Ileus (HP:0002595) | 2.07716254 |
| 108 | T lymphocytopenia (HP:0005403) | 2.05883526 |
| 109 | Respiratory distress (HP:0002098) | 2.05822779 |
| 110 | Papillary thyroid carcinoma (HP:0002895) | 2.05566005 |
| 111 | Ketosis (HP:0001946) | 2.05439636 |
| 112 | Increased connective tissue (HP:0009025) | 2.04198396 |
| 113 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03887939 |
| 114 | Rhabdomyolysis (HP:0003201) | 2.02501546 |
| 115 | Abnormality of T cell number (HP:0011839) | 2.02080498 |
| 116 | Hyperammonemia (HP:0001987) | 2.00239167 |
| 117 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99222432 |
| 118 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99222432 |
| 119 | Autoimmune hemolytic anemia (HP:0001890) | 1.98574454 |
| 120 | Toxemia of pregnancy (HP:0100603) | 1.98504963 |
| 121 | Albinism (HP:0001022) | 1.97024447 |
| 122 | Paralysis (HP:0003470) | 1.95913069 |
| 123 | Conjunctival hamartoma (HP:0100780) | 1.95197566 |
| 124 | Onion bulb formation (HP:0003383) | 1.94254318 |
| 125 | Tubulointerstitial fibrosis (HP:0005576) | 1.94129309 |
| 126 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.93873951 |
| 127 | Absent/shortened dynein arms (HP:0200106) | 1.93873951 |
| 128 | Systemic lupus erythematosus (HP:0002725) | 1.93754263 |
| 129 | Chest pain (HP:0100749) | 1.93712580 |
| 130 | Mediastinal lymphadenopathy (HP:0100721) | 1.93198862 |
| 131 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92100122 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.91885846 |
| 133 | Difficulty running (HP:0009046) | 1.91593504 |
| 134 | Hypotrichosis (HP:0001006) | 1.91176955 |
| 135 | Sensory axonal neuropathy (HP:0003390) | 1.91126770 |
| 136 | Hemoptysis (HP:0002105) | 1.90893568 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90768770 |
| 138 | Leukocytosis (HP:0001974) | 1.90276166 |
| 139 | Pulmonary embolism (HP:0002204) | 1.88060988 |
| 140 | Impaired platelet aggregation (HP:0003540) | 1.87766389 |
| 141 | Abnormal platelet function (HP:0011869) | 1.87766389 |
| 142 | Glomerulopathy (HP:0100820) | 1.86532518 |
| 143 | Palmoplantar hyperkeratosis (HP:0000972) | 1.85398810 |
| 144 | Skin ulcer (HP:0200042) | 1.84917572 |
| 145 | * Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.83767368 |
| 146 | Increased IgM level (HP:0003496) | 1.82745152 |
| 147 | Protuberant abdomen (HP:0001538) | 1.82124440 |
| 148 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81932790 |
| 149 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81932790 |
| 150 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81932790 |
| 151 | Hyperglycinemia (HP:0002154) | 1.81392233 |
| 152 | Pancreatitis (HP:0001733) | 1.79807643 |
| 153 | Oral leukoplakia (HP:0002745) | 1.79472112 |
| 154 | Periodontitis (HP:0000704) | 1.79208107 |
| 155 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78992393 |
| 156 | Acne (HP:0001061) | 1.77868477 |
| 157 | Follicular hyperkeratosis (HP:0007502) | 1.76730829 |
| 158 | Ventricular tachycardia (HP:0004756) | 1.75892527 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.75120149 |
| 160 | Nephritis (HP:0000123) | 1.72791923 |
| 161 | Joint hemorrhage (HP:0005261) | 1.71883081 |
| 162 | Abnormal tarsal ossification (HP:0008369) | 1.70852407 |
| 163 | Femoral bowing (HP:0002980) | 1.70349039 |
| 164 | Spinal rigidity (HP:0003306) | 1.69918730 |
| 165 | Peritonitis (HP:0002586) | 1.68671677 |
| 166 | Exercise-induced muscle cramps (HP:0003710) | 1.68135477 |
| 167 | Cupped ribs (HP:0000887) | 1.67974309 |
| 168 | Erythroderma (HP:0001019) | 1.66278846 |
| 169 | Premature skin wrinkling (HP:0100678) | 1.63933448 |
| 170 | Bone cyst (HP:0012062) | 1.63413939 |
| 171 | Difficulty walking (HP:0002355) | 1.63404863 |
| 172 | Urticaria (HP:0001025) | 1.62427046 |
| 173 | Bell-shaped thorax (HP:0001591) | 1.61728112 |
| 174 | Ketoacidosis (HP:0001993) | 1.61693753 |
| 175 | Prolonged neonatal jaundice (HP:0006579) | 1.61635383 |
| 176 | Skin nodule (HP:0200036) | 1.61621724 |
| 177 | Gingivitis (HP:0000230) | 1.61451312 |
| 178 | Hypolipoproteinemia (HP:0010981) | 1.61430328 |
| 179 | Oligomenorrhea (HP:0000876) | 1.61315032 |
| 180 | Prolonged partial thromboplastin time (HP:0003645) | 1.60966388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.66360803 |
| 2 | PDK3 | 3.30105119 |
| 3 | PDK4 | 3.30105119 |
| 4 | PDK2 | 3.19145952 |
| 5 | SIK1 | 3.14615441 |
| 6 | CAMK1D | 3.01125878 |
| 7 | STK39 | 2.99222648 |
| 8 | PBK | 2.65544260 |
| 9 | EPHB1 | 2.61790260 |
| 10 | KSR2 | 2.55956205 |
| 11 | BCKDK | 2.45601675 |
| 12 | MAP3K2 | 2.45232402 |
| 13 | TYK2 | 2.41277285 |
| 14 | TESK1 | 2.34148162 |
| 15 | BMPR2 | 2.20051889 |
| 16 | TRPM7 | 2.16621339 |
| 17 | MST1R | 2.12896587 |
| 18 | ZAP70 | 2.05254360 |
| 19 | MET | 2.03030266 |
| 20 | WNK4 | 1.94287767 |
| 21 | CAMK1G | 1.94146875 |
| 22 | MAP3K3 | 1.89850363 |
| 23 | EIF2AK1 | 1.85189977 |
| 24 | ACVR1B | 1.84998420 |
| 25 | GRK6 | 1.82541339 |
| 26 | PIK3CA | 1.78780804 |
| 27 | FGFR2 | 1.78340580 |
| 28 | JAK2 | 1.76980797 |
| 29 | TAOK3 | 1.71538433 |
| 30 | TRIB3 | 1.69830368 |
| 31 | JAK3 | 1.62918440 |
| 32 | MAP3K1 | 1.59020694 |
| 33 | TTN | 1.57118617 |
| 34 | MAP3K12 | 1.57084267 |
| 35 | MAP3K6 | 1.55849401 |
| 36 | TAOK1 | 1.53215139 |
| 37 | RAF1 | 1.50037485 |
| 38 | ERN1 | 1.48514657 |
| 39 | PIK3CG | 1.46210522 |
| 40 | PRPF4B | 1.45002414 |
| 41 | EPHA3 | 1.44869994 |
| 42 | IRAK4 | 1.43466293 |
| 43 | TIE1 | 1.38313090 |
| 44 | STK38 | 1.37759340 |
| 45 | LIMK1 | 1.35371405 |
| 46 | KSR1 | 1.35076840 |
| 47 | INSRR | 1.30983857 |
| 48 | STK24 | 1.29661341 |
| 49 | TAOK2 | 1.29315020 |
| 50 | HCK | 1.28757227 |
| 51 | IRAK1 | 1.26867271 |
| 52 | PKN1 | 1.24680190 |
| 53 | MAPKAPK5 | 1.24182021 |
| 54 | MARK3 | 1.22366796 |
| 55 | SIK3 | 1.20992354 |
| 56 | TGFBR2 | 1.16394568 |
| 57 | IKBKE | 1.15672618 |
| 58 | OXSR1 | 1.15415916 |
| 59 | MAP3K14 | 1.14368425 |
| 60 | NEK9 | 1.14091618 |
| 61 | RIPK1 | 1.06762530 |
| 62 | BTK | 1.06023008 |
| 63 | TEC | 1.05117221 |
| 64 | PRKAA2 | 1.04008952 |
| 65 | FRK | 1.01234125 |
| 66 | MAP3K5 | 1.00956588 |
| 67 | LMTK2 | 1.00682189 |
| 68 | FES | 0.98818687 |
| 69 | YES1 | 0.98750376 |
| 70 | ABL2 | 0.94707163 |
| 71 | EIF2AK2 | 0.89118401 |
| 72 | EPHB2 | 0.86239053 |
| 73 | BCR | 0.84904932 |
| 74 | GSK3A | 0.84690854 |
| 75 | SGK223 | 0.83571947 |
| 76 | SGK494 | 0.83571947 |
| 77 | LATS1 | 0.83137312 |
| 78 | IKBKB | 0.82155103 |
| 79 | TBK1 | 0.82124301 |
| 80 | PTK2B | 0.82009094 |
| 81 | LYN | 0.81454954 |
| 82 | DYRK3 | 0.81000252 |
| 83 | SYK | 0.80474787 |
| 84 | ERBB4 | 0.80368730 |
| 85 | PIM1 | 0.79817723 |
| 86 | STK3 | 0.79760814 |
| 87 | OBSCN | 0.79003419 |
| 88 | MAP2K3 | 0.78619982 |
| 89 | IRAK2 | 0.77503171 |
| 90 | PDGFRB | 0.76803908 |
| 91 | PDPK1 | 0.73971166 |
| 92 | MAP2K1 | 0.73613325 |
| 93 | IRAK3 | 0.73424135 |
| 94 | BMX | 0.72132482 |
| 95 | PIM2 | 0.71661341 |
| 96 | CLK1 | 0.70819809 |
| 97 | WNK1 | 0.70521658 |
| 98 | FGFR4 | 0.70103995 |
| 99 | STK4 | 0.69581293 |
| 100 | MOS | 0.69254006 |
| 101 | MATK | 0.67330614 |
| 102 | PAK4 | 0.66522803 |
| 103 | FER | 0.64163601 |
| 104 | BMPR1B | 0.63141605 |
| 105 | GRK1 | 0.62511003 |
| 106 | BLK | 0.62254245 |
| 107 | DDR2 | 0.62140725 |
| 108 | PRKD1 | 0.61245676 |
| 109 | ZAK | 0.58593933 |
| 110 | STK10 | 0.55151742 |
| 111 | MAP3K8 | 0.54035753 |
| 112 | PTK6 | 0.52645988 |
| 113 | PRKCE | 0.52038290 |
| 114 | EIF2AK3 | 0.51729010 |
| 115 | TNK2 | 0.51689893 |
| 116 | TXK | 0.50558851 |
| 117 | ILK | 0.50495369 |
| 118 | LCK | 0.49818961 |
| 119 | MAPK12 | 0.49799059 |
| 120 | CDK6 | 0.49674185 |
| 121 | CSK | 0.49592359 |
| 122 | SGK3 | 0.48979174 |
| 123 | STK38L | 0.48484886 |
| 124 | ERBB3 | 0.48312234 |
| 125 | CAMK2D | 0.48088615 |
| 126 | RET | 0.47491489 |
| 127 | FGR | 0.47304779 |
| 128 | PHKG2 | 0.47258139 |
| 129 | PHKG1 | 0.47258139 |
| 130 | PINK1 | 0.46300398 |
| 131 | MAP2K4 | 0.46147680 |
| 132 | GRK5 | 0.46088299 |
| 133 | PRKAA1 | 0.45918367 |
| 134 | ABL1 | 0.45850134 |
| 135 | MST4 | 0.45203288 |
| 136 | PRKG2 | 0.44896603 |
| 137 | JAK1 | 0.43457152 |
| 138 | MAP4K1 | 0.42977319 |
| 139 | PRKCQ | 0.42475608 |
| 140 | GRK7 | 0.42019885 |
| 141 | PDK1 | 0.39552962 |
| 142 | MYLK | 0.38711555 |
| 143 | DYRK2 | 0.38705463 |
| 144 | PRKACG | 0.37965706 |
| 145 | MAPK4 | 0.37438996 |
| 146 | DAPK3 | 0.37093278 |
| 147 | TESK2 | 0.37004702 |
| 148 | NLK | 0.36821396 |
| 149 | LRRK2 | 0.36323693 |
| 150 | KDR | 0.35858698 |
| 151 | ADRBK1 | 0.35137652 |
| 152 | NME2 | 0.34624598 |
| 153 | MAPKAPK2 | 0.34521630 |
| 154 | NEK6 | 0.34382600 |
| 155 | MAP3K11 | 0.30817800 |
| 156 | FGFR3 | 0.30761780 |
| 157 | SGK2 | 0.30753744 |
| 158 | AKT3 | 0.28496200 |
| 159 | TRIM28 | 0.28299775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.61659320 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22404334 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.87062574 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.80257071 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.79746515 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.77676313 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.76436465 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.74668994 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54326938 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50113000 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35302601 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.34638682 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04125605 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.90750396 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89094894 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.85938378 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.75441841 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73519007 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73092533 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70548257 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66646170 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66085852 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65600338 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.65203521 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63570706 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59629025 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57041805 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54504788 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.54369911 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53948726 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.53684790 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51639154 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.51533878 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48369369 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.47913158 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45647982 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.45295702 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43104913 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42479383 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41873345 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41742316 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41233926 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.39726181 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39381147 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39329363 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38102189 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36286735 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35028806 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33020991 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31407182 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31363530 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31240823 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.29152407 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29052931 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27916533 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26574510 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26166952 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25372326 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19918858 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19865140 |
| 61 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.19848796 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18539186 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14108695 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13609949 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 1.13516201 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11643369 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10901066 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10467341 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10026545 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.09319692 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07436726 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07230012 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06962674 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05329918 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02904186 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00464050 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00435452 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99975052 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.99365995 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.97544256 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96345233 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95374304 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95120872 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94622535 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.93661879 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93571014 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92088332 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91981193 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91753417 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90674550 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89590405 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.88112570 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87396374 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86372649 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85588404 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85450357 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85026685 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.84082812 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81280831 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81248709 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80701348 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77672243 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72797716 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71688898 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71104380 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.69643741 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68347727 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.67991049 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65330970 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65184369 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64855541 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63607535 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63604638 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63377663 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62781953 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62779341 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62167706 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.60195028 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60001763 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.59565442 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58195401 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56537198 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56461926 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.51709118 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50278563 |
| 126 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50260382 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49740401 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46975322 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46829552 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.46738420 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45998357 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44829031 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44552015 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44076873 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44016839 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42779909 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.42200915 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.40564603 |
| 139 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40424911 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40302988 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40249007 |
| 142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39325839 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36731852 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35767993 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35199466 |
| 146 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30717801 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30666374 |
| 148 | Legionellosis_Homo sapiens_hsa05134 | 0.29335222 |
| 149 | Focal adhesion_Homo sapiens_hsa04510 | 0.27697832 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.24526225 |
| 151 | Tight junction_Homo sapiens_hsa04530 | 0.24135123 |
| 152 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23659951 |
| 153 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21432788 |
| 154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21034879 |
| 155 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20819088 |
| 156 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.20253888 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | 0.19578984 |
| 158 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19499627 |
| 159 | Salmonella infection_Homo sapiens_hsa05132 | 0.19463597 |
| 160 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18272624 |
| 161 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17987013 |
| 162 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.16467436 |
| 163 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.16427968 |

